Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target

This study has been completed.
Sponsor:
Collaborator:
Medtronic
Information provided by (Responsible Party):
Diabetes Care Center
ClinicalTrials.gov Identifier:
NCT01548222
First received: February 27, 2012
Last updated: August 23, 2013
Last verified: August 2013